10-K Filing

BENITEC BIOPHARMA INC. CIK: 1808898 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001193125-22-237075`
Period End Date	20220630
Filing Date	20220902
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	d360350d10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 38 Cash Flow Statement 48 Stockholders Equity 15

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	40.00M	shares	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	40.00M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	8.17M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	8.17M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.77M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.06M	USD	Point-in-time
Restricted Cash	`RestrictedCashCurrent`	$14.00K	USD	Point-in-time
Restricted Cash	`RestrictedCashCurrent`	$15.00K	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	8.17M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	8.17M	shares	Point-in-time
Trade and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$3.00K	USD	Point-in-time
Trade and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$25.00K	USD	Point-in-time
Prepaid and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$741.00K	USD	Point-in-time
Prepaid and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$799.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.82M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.61M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$222.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$375.00K	USD	Point-in-time
Deposits	`DepositAssets`	$9.00K	USD	Point-in-time
Deposits	`DepositAssets`	$25.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$135.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$185.00K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$202.00K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$771.00K	USD	Point-in-time
Total assets	`Assets`	$21.38M	USD	Point-in-time
Total assets	`Assets`	$5.97M	USD	Point-in-time
Trade and other payables	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$880.00K	USD	Point-in-time
Trade and other payables	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$1.88M	USD	Point-in-time
Accrued employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$276.00K	USD	Point-in-time
Accrued employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$400.00K	USD	Point-in-time
Lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$213.00K	USD	Point-in-time
Lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$252.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.37M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.53M	USD	Point-in-time
Lease liabilities, less current portion	`OperatingLeaseLiabilityNoncurrent`	$559.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.37M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.09M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.0001 par value40,000,000 shares authorized; 8,171,690 shares issued and outstanding at June 30, 2022 and 2021	`CommonStockValue`	$1.00K	USD	Point-in-time
Common stock, $0.0001 par value40,000,000 shares authorized; 8,171,690 shares issued and outstanding at June 30, 2022 and 2021	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$151.58M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$152.45M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-148.33M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-130.12M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.25M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.46M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$2.88M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.01M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.24M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$21.38M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.97M	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Revenues from customers	`RevenueFromContractWithCustomerIncludingAssessedTax`	$59.00K	USD	Annual
Revenues from customers	`RevenueFromContractWithCustomerIncludingAssessedTax`	$73.00K	USD	Annual
Royalties and license fees	`RoyaltiesAndLicenseFees`	$9.00K	USD	Annual
Royalties and license fees	`RoyaltiesAndLicenseFees`	$123.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$7.02M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$11.27M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.51M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.65M	USD	Annual
Total operating expenses	`OperatingExpenses`	$13.65M	USD	Annual
Total operating expenses	`OperatingExpenses`	$17.93M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-17.85M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-13.60M	USD	Annual
Foreign currency transaction loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-333.00K	USD	Annual
Foreign currency transaction loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-232.00K	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-6.00K	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-32.00K	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$37.00K	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-79.00K	USD	Annual
Unrealized gain (loss) on investment	`UnrealizedGainLossOnInvestments`	$16.00K	USD	Annual
Unrealized gain (loss) on investment	`UnrealizedGainLossOnInvestments`	$-11.00K	USD	Annual
Total other loss, net	`NonoperatingIncomeExpense`	$-286.00K	USD	Annual
Total other loss, net	`NonoperatingIncomeExpense`	$-354.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-13.88M	USD	Annual
Net loss	`NetIncomeLoss`	$-18.21M	USD	Annual
Unrealized foreign currency translation gain	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$498.00K	USD	Annual
Unrealized foreign currency translation gain	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$210.00K	USD	Annual
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$498.00K	USD	Annual
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$210.00K	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-13.38M	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-18.00M	USD	Annual
Basic	`EarningsPerShareBasic`	$-3.23	USD	Annual
Basic	`EarningsPerShareBasic`	$-2.23	USD	Annual
Diluted	`EarningsPerShareDiluted`	$-3.23	USD	Annual
Diluted	`EarningsPerShareDiluted`	$-2.23	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	4.30M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	8.17M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	8.17M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	4.30M	shares	Annual

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-13.88M	USD	Annual
Net loss	`NetIncomeLoss`	$-18.21M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$167.00K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$231.00K	USD	Annual
Amortization of right-of-use assets	`AmortizationOfRightOfUseAssets`	$193.00K	USD	Annual
Amortization of right-of-use assets	`AmortizationOfRightOfUseAssets`	$225.00K	USD	Annual
Unrealized (gain) loss on investment	`UnrealizedGainLossOnInvestment`	$16.00K	USD	Annual
Unrealized (gain) loss on investment	`UnrealizedGainLossOnInvestment`	$-10.00K	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$634.00K	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$870.00K	USD	Annual
Trade and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-1.00K	USD	Annual
Trade and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-28.00K	USD	Annual
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.00K	USD	Annual
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-62.00K	USD	Annual
Trade and other payables	`IncreasedecreaseInAccountsAndOtherPayables`	$55.00K	USD	Annual
Trade and other payables	`IncreasedecreaseInAccountsAndOtherPayables`	$1.09M	USD	Annual
Accrued employee benefit payable	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$80.00K	USD	Annual
Accrued employee benefit payable	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$121.00K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiabilities`	$-192.00K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiabilities`	$-196.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.83M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-15.90M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$221.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$13.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-221.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-13.00K	USD	Annual
Proceeds from issues of shares and pre-funded warrants	`ProceedsFromIssuanceOfCommonStock`	$25.75M	USD	Annual
Share issue transaction costs	`PaymentsOfStockIssuanceCosts`	$3.23M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$22.52M	USD	Annual
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$499.00K	USD	Annual
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$204.00K	USD	Annual
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$9.97M	USD	Annual
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-15.71M	USD	Annual
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.78M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.08M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.82M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.78M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.08M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.82M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.77M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.06M	USD	Point-in-time
Restricted Cash	`RestrictedCashCurrent`	$14.00K	USD	Point-in-time
Restricted Cash	`RestrictedCashCurrent`	$15.00K	USD	Point-in-time
Total cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.78M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.08M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.82M	USD	Point-in-time
Re-measurement of operating lease right-of-use assets and liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	Annual
Re-measurement of operating lease right-of-use assets and liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$794.00K	USD	Annual

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Payments For Stock Issuance Costs	`PaymentsOfStockIssuanceCosts`	$3.23M	USD	Annual
Balance at the beginning	`StockholdersEquity`	$2.88M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$20.01M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$10.24M	USD	Point-in-time
Issuance of common stock and pre-funded warrants sold for cash, net of offering costs of $3,228	`IssuanceAndExerciseOfPrefundedWarrantsNetOfTransactionCosts`	$22.52M	USD	Annual
Exercise of pre-funded warrants	`WarrantsExercisedValueDuringThePeriod`	$3.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$870.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$634.00K	USD	Annual
Foreign currency translation loss (Gain)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$498.00K	USD	Annual
Foreign currency translation loss (Gain)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$210.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-13.88M	USD	Annual
Net loss	`NetIncomeLoss`	$-18.21M	USD	Annual
Balance at end	`StockholdersEquity`	$2.88M	USD	Point-in-time
Balance at end	`StockholdersEquity`	$20.01M	USD	Point-in-time
Balance at end	`StockholdersEquity`	$10.24M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.